Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children.

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

A Winnipeg woman who trained as a doctor in the Philippines says she doesn't trust the Manitoba health care system after ...

Heavy smoke and poor air quality are expected to aggravate symptoms for people with airway diseases, such as asthma, pulmonary fibrosis and chronic obstructive pulmonary disease. Cedars-Sinai said its ...

Time is morbidity and mortality (and money), and guidelines recommend sepsis screening on the hospital wards. Two studies ...